Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate
Denosumab May Help Prevent Bone Loss
Past Highlights
Results:
1 -10 of 14
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II/III Trial of CPT-11/5-FU/l-LV Versus CPT-11/TS-1 as Second Line Chemotherapy of Unresectable Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
20 to 75
Pharmaceutical / Industry
01023010 / TOP-003
NCT00284258
2.
A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
20 to 75
Other
JCOG9912
C000000062, NCT00142350
3.
Study of S-1, S-1/CDDP, and 5-FU/CDDP for Advanced Gastric Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
18 and over
Pharmaceutical / Industry
SC101
NCT00202969
4.
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Temporarily closed
18 to 75
Other
HGCSG0601
IFOX study, NCT00316745
5.
Phase 1/2 Study of S-1 and Cisplatin in Advanced Gastric Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Closed
18 and over
Pharmaceutical / Industry
TPU-S1101; ID02-694
NCT00072787
6.
Phase I/II Study of Oral S-1 Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Temporarily closed
20 to 75
Other
HGCSG0405
GEMS-1, NCT00209677
Last Modified:
6/1/2000
 
First Published:
9/1/1999
7.
Phase II Study of S-1 in Patients With Locally Advanced, Metastatic, or Unresectable Gastric or Colorectal Cancer (Summary Last Modified 06/2000)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
EORTC-16972C/G
TAIHO-EORTC-16972C/G
Last Modified:
4/20/2007
 
First Published:
9/23/2005
8.
Phase II Study of S-1 as Second-Line Therapy in Patients With Metastatic Pancreatic Cancer Previously Treated With Gemcitabine
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
QUINT-TPU-S1201
TAIHO-QUINT-TPU-S1201, NCT00227604
Last Modified:
6/30/2006
 
First Published:
9/23/2005
9.
Phase II Study of S-1 and Cisplatin as First-Line Therapy in Patients With Unresectable Stage IIIB or IV Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
QUINT-TPU-S1202
TAIHO-QUINT-TPU-S1202, NCT00227578
Last Modified:
12/14/2006
 
First Published:
9/23/2005
10.
Phase II Study of S-1 as Second-Line Therapy in Patients With Unresectable or Recurrent Stage IIIB or IV Non-Small Cell Lung Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Closed
18 and over
Pharmaceutical / Industry
QUINT-TPU-S1203
TAIHO-QUINT-TPU-S1203, NCT00227552
Select All on One Page
1
2
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute